key: cord-0808609-qohv528z authors: Costa, Guilherme Jorge; Filho, Hélio de Araújo de Fonseca; Malta, Fábio Costa; Bitu, Felipe Costa Leandro; Barbosa, Claudia; de Sá, Josenildo; Amarante, André; Thuler, Luiz Claudio Santos title: The Impact of the COVID-19 pandemic on tertiary care cancer center: analyzing administrative data date: 2022-04-15 journal: Semin Oncol DOI: 10.1053/j.seminoncol.2022.04.004 sha: 8c4ca3d9eaebc4b6f4ac7fe7a34d17ef0662f316 doc_id: 808609 cord_uid: qohv528z INTRODUCTION: Patients with cancer need to receive their proper treatment and often cannot wait for their treatment, despite delays due to the COVID-19 pandemic. As a result, many cancer centers have had challenges maintaining their oncological activities. OBJECTIVES: To compare the average hospital management data and indicators in two different periods, with and without the peak of COVID-19 cases, from an important tertiary cancer center in the northeast region of Brazil. METHODS: A retrospective and observational study was performed comparing average hospital administrative data and indicators, between January to March versus April to June, 2020 exclusively at the Hospital de Câncer de Pernambuco, Brazil. RESULTS: There were on average a 13% reduction in the chemotherapy administered (p = 0•131), 17% fewer radiotherapy treatments carried out (p = 0•043) and 41% as many oncologic surgeries undertaken (p = 0•002). There was a reduction in the number of sessions of out-patient chemotherapy of 8•6% (p = 0•271) and chemotherapy inpatients of 33% (p = 0•038). Admission of new cases of patients with cancer was reduced by 44% (p = 0•007) during the period analyzed. Ambulatory appointments also decreased by 55% (p = 0•004) and emergency room appointments fell by 7•9% (p = 0•495). The number of hospitalizations was reduced by 36% (p = 0•005) and the occupancy rate decreased by 23•6% (p = 0•003), while the length of individual hospital stay (in days) increased 10•5% (p = 0•116). CONCLUSION: We report a reduction in the number of radiotherapy treatments and surgeries performed cancer carried out, ambulatory and emergency appointments, hospitalization and admission of new cases of cancer during peak of COVID-19 in an important public tertiary cancer center in the northeast region of Brazil. The emergence of coronavirus disease 2019 (COVID- 19) caused an unprecedented public health challenge worldwide beginning in December 2019. 1 Globally, as of 1 October 2021, 233,503,524 confirmed cases of COVID-19, including 4,777,503 deaths, had been reported to WHO. 2 In Brazil, from 3 January 2020 to 1 October 2021, 21 ,399,546 confirmed cases of COVID-19 and 596,122 deaths, had been reported to WHO with Pernambuco, a federation state of Brazil located in the northeast region, a major source of cases. 3 Cancer also remains a serious public health threat worldwide, 4 and patients with cancer are considered a high-risk population to acquire infectious diseases, including COVID-19. 5 Moreover, cancer patients usually develop severe disease when infected with SARS-CoV-2, 6 although it is unclear if cytotoxic chemotherapy worsens the prognosis of cancer patients to coronavirus. 7 Oncologic operations have been reduced during the outbreak of COVID-19, 8 even though patients with cancer often need to receive proper treatment and cannot wait or delay treatment despite the COVID-19 pandemic. 9 Furthermore, during oncologic treatment, patients may require more hospitalization, ambulatory, or emergency appointments, exams, or other procedures. 10 As a consequence, cancer centers have had to carefully structure or organize their capacity to minimize the reduction in new cancer diagnoses and to continue oncologic treatment during the coronavirus pandemic. 10 For cancer centers, maintaining oncologic activities has been challenging. 11 Issues that have arisen during the COVID-19 pandemic have included resource allocation, medication shortage, separation of patients that have tested positive or negative for COVID, establishing clear communication between staff, patients, and their relatives, giving medical and psychological support for many health professionals that are infected or ill, and quickly hiring new professionals. 10, 12 It has thus not been surpising that the capacity of oncologic care in cancer centers has been considerably affected during the pandemic. 12 The aim of this study was to evaluate routine services for new cases admitted, ambulatory and emergency visits, hospitalizations and the kind of oncologic treatment offered between 1 January to 30 June 2020, through as difficult period in a tertiary cancer center in the northeast region of Brazil. A retrospective and observational study was performed evaluating hospital management data and indicators, between 1 January up to 30 June 2020, exclusively at the Hospital de Câncer de Pernambuco (HCP). HCP is in Recife city, Brazil and is a reference institution for the prevention, diagnosis and treatment of cancer. HCP receives patients from different cities from the state of Pernambuco. HCP is a non-profit oncologic health institution, founded 74 years ago, whose hospital care is only provided free of charge within Brazil's Unified Public Health System (SUS), to patients who are not insured. It has 250 beds, and during the study period, this hospital was not considered for referrals for diagnosis and treatment of COVID-19, albeit it diagnosed and treated patients with cancer and COVID-19. The hospital has an emergency room, critical care units, operating room, image (ultrasound, x-ray and tomography) service, radiotherapy sector, chemotherapy sector, clinical laboratory, pharmacy sector, wards, ambulatory sector and teaching and research departments. The first two cases of COVID-19 in Pernambuco were reported on the same day, 12 March 2020, by both the state and municipal health department of Pernambuco. The peak of cases in the state was reported between April to June and was evaluated in this study. Thus, hospital management data from January to March -considered a period of normal assistance for cancer patients -was used as a comparison period. To evaluate the impact of COVID-19 at HCP the following variables were collected: the average number of new cases admitted to HCP, the number of general ambulatory appointments, the number of emergency visits, the number of hospitalizations, the length of stay, occupancy rate, number of surgeries performed and chemotherapy and radiotherapy sessions. These variables were harvested for each month between January to March (comparison period) and compared to the average of each variable from April to June (pandemic period). The Statistical Package for the Social Sciences (SPSS), version 23.0, was used in the statistical analysis. A descriptive analysis was performed using mean and standard deviation (± SD) for each numeric variable analyzed. The Student t-test was used to identify differences between groups for continuous data. Differences were considered statistically significant when p-values were <0.05. A relative percentage change (RPC) was calculated by dividing the change from the first to the second trimester by the figure in the first trimester x 100. Ethical committee approval was not required, because only hospital management data and indicators were used, as stipulated in resolution 466/2012 of the Brazilian National Health Council. Patients' data were not evaluated. During 1 January to 30 June, 2020, no beds, wards, sectors or departments were closed. One critical care unit with ten beds and one COVID-19 ward with 14 beds were adapted for patients with a diagnosis of cancer suspected or confirmed to have COVID-19. If this ward and/or critical care unit was full, patients suspected or confirmed could be transported to another COVID-19 reference hospital. Our oncology team created restricted access to caregivers and relatives of inpatients in the hospital and banned gatherings. Personal protective equipment (PPE) was available for all health professionals who were working in COVID-19 sectors, including hydroalcoholic hand wash solutions, proper scrubs, or gowns, N95 masks, gloves and eye protection. Priority was given to avoid interruptions or delay to start chemotherapy and radiotherapy. Medical staff could decide together with the patient to carry out, postpone or cancel their surgical treatment. Comparing the period of April-June with January-March the chemotherapy administered was reduced on average 13% (p = 0·131), 17% fewer radiotherapy sessions were undertaken (p = 0·043), and 41% less oncologic surgeries performed (p = 0·002). Analyzing data of ambulatory chemotherapy also showed a reduction in the number of sessions by 8·6%, but this was not statistically significant (p = 0·271), albeit the number of chemotherapy inpatients decreased by 33% (p = 0·038) ( Table 1) . New patients admitted with a diagnosis of cancer fell by 44% (p = 0·007) during the period analyzed. Ambulatory appointments also decreased by 55%, and this was statistically significant (p = 0·004). Emergency room appointments also fell by 7·9% (p = 0·495) ( Table 1) . The number of hospitalizations was also evaluated and found to be reduced by 36% (p = 0·005), while occupancy rate decreased by 23·6% (p = 0·003) between April to June compared to January to March. The length of hospital stay (in days) increased 10·5% (p = 0·116) ( Table 1) . By comparing data of different oncologic treatments administered at Hospital de Câncer de Pernambuco (HCP) from January-March with that of April-June 2020, we found a significant reduction in the demand for oncology care. From the patient's perspective, this study showed that chemotherapy sessions were maintained during the peak of During the COVID-19 pandemic, oncologic treatment could be offered or postponed. 10 This has become an important dilemma for oncologists. The risk of developing COVID-19 during treatment or progression of cancer could happen if the treatment is delayed. In this study, the number of radiotherapy treatments and surgeries performed for cancer were reduced significantly, but this was not the case for chemotherapy. Chang et al. also reported a decreased number of oncologic surgeries. 8 A cohort of patients with cancer and COVID-19 were identified, and amongst these increased age, male gender, smoking status, low performance status and active cancer were negative prognostic factors. However, the type of anticancer therapy and recent surgery were not associated with mortality. 5, 7 Delaying treatment of cancer also could reduce survival and quality of life 9 , including for patients needing surgical interventions. 13 Thus, keeping ongoing anticancer therapy for advanced stages and/or curative intentions benefits patients. 14 Oncologic surgery often gives patients with a diagnosis of cancer the best chance of cure, but elective surgical procedures in stable cancers should be postponed. 11 15 In HCP, surgical procedures involving thyroid cancer, nonmelanoma skin cancer and gynecologic are very common, and were one of reasons for the reductions in the number of elective surgeries during the COVID-19 pandemic. Moreover, intensive care beds reserved for assisting complex surgeries of patients with cancer were transformed into COVID-19 beds for patients with associated critical illness. Third, the operating room team was reduced because many health professionals were away from work due to illness or were of an age and/or had comorbidities considered high-risk to develop COVID-19. Finally, many patients treated in HCP are from the rural areas of Pernambuco, whose travel or mobility was dramatically reduced during the outbreak. HCP had hoped to avoid suspensions or delays in the administration of radiotherapy and chemotherapy however this study showed a reduction in the number of radiotherapy and chemotherapy sessions. This occurred despite the institution of new radiotherapy strategies to reduce the risk of patients with cancer becoming infected. 9 , 10 Shorter treatments courses and avoidance of twice-daily radiotherapy was done to minimize ambulatory appointments. Cytotoxic chemotherapy was not included because it was feared patients would be more susceptible to die of coronavirus infections. 7 Additionally, educational calls and guidance campaigns were offered to patients and family members to encourage patients to continue oncologic treatment during the pandemic. Vacations by health professionals were postponed and new health professionals were hired. There was no drop in the availability of cytotoxic drugs used by oncologists during this period. Despite this, ambulatory consultations fell by 55%, while the number of hospitalizations fell by 36% and the number of chemotherapy inpatients decreased by 33%. The fall in the number of hospitalizations was driven in part by 44% fewer admissions to HCP for new cases of cancer during the outbreak, meaning fewer patients were diagnosed and treated in this period. Similar difficulties have been reported worldwide [ Table 2 ] We anticipate that in the ensuing months after the outbreak, we will likely see an increased number of appointments or hospitalizations of patients with new diagnoses of cancer, but with histories of symptoms of longer duration. From the hospital's perspective, the financial management and stability of the cancer center was very difficult during the COVID-19 pandemic. As an institution, the financial situation of a hospital requires maintaining the production of oncologic services. Furthermore, many hospitals with limited financial capacity and flexibility, needed to divert resources to address the increased number of COVID-19 cases. 34 This study demonstrates that many of the interventions that generate revenue were significantly reduced possibly affecting the quantity and quality of oncologic assistance in this pandemic period, an possibly in the future. This will likely require robust and sustained financial support by the government to avoid further delays or cancellation of oncologic assistance. This study has some limitations. First, the analysis was retrospective. Second, data was from just one Cancer Center, which cannot be generally representative. Finally, the cancelled or delayed oncologic treatments of each patient were not individually assessed, preventing a more reliable analysis. However, the study was based on hospital management data and indicators from an important tertiary cancer center responsible for the majority of oncology cases in the state of Pernambuco in Brazil. The information obtained in this study can be valuable for understanding and coping with the current impact of the pandemic for both the patient and oncology institutions in Brazil. Consequently, the information can be used for planning and implementation of public health policies and to ensure financial support guarantees prevention, diagnosis and appropriate oncologic treatment during a pandemic. Finally, this data also could support oncologic management in a future epidemic or pandemic. In conclusion, this study showed a reduction in the quantity of oncologic radiotherapy and surgeries performed, ambulatory and emergency appointments, and hospitalizations and admission of new cases of cancer in an important tertiary cancer center during the peak of cases of COVID-19 in the northeast region of Brazil, despite instituting measures to avoid a fall in the quantity and quality of cancer care and in the billing of the health institution. A novel coronavirus from patients with pneumonia in China Ministério da saúde Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study Cancer is associated with severe disease in COVID-19 patients: a systematic review and meta-analysis COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study Flattening the curve in oncologic surgery: Impact of COVID-19 on surgery at tertiary care cancer centre Treatment delays in oncology patients during COVID-19 pandemic: A perspective A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 ( COVID -19) Pandemic: An International Collaborative Group The Impact of the COVID-19 Pandemic on Cancer Patients Organisational challenges , volumes of oncological activity and patients ' perception during the severe acute respiratory syndrome coronavirus 2 epidemic Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic Impact of the COVID-19 Outbreak on the Management of Patients with Cancer A War on Two Fronts: Cancer Care in the Time of COVID-19 Impact of the COVID-19 pandemic on skin cancer diagnosis: A population-based study PLoS One The impact of the COVID-19 pandemic on cancer diagnosis and service access in New Zealand-a country pursuing COVID-19 elimination Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands Cancer diagnosed during the COVID-19 pandemic in the Faroe Islands The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study Effects of the COVID-19 Pandemic on Cancer-Related Patient Encounters Collateral effects of the coronavirus disease 2019 pandemic on lung cancer diagnosis in Korea Impact of COVID-19 on Cancer Care: How the Pandemic Is Delaying Cancer Diagnosis and Treatment for American Seniors Impact of the COVID-19 pandemic during Spain's state of emergency on the diagnosis of colorectal cancer Impact of the COVID-19 Pandemic on Cancer Diagnoses in General and Specialized Practices in Germany. Cancers (Basel) Cancer diagnosis in Brazil in the COVID-19 era Cancer diagnostic rates during the 2020 'lockdown', due to COVID-19 pandemic, compared with the 2018-2019: an audit study from cellular pathology Cancer Screening Tests and Cancer Diagnoses During the COVID-19 Pandemic Siesling S; NABON COVID-19 Consortium and the COVID and Cancer-NL Consortium. Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study Association of the COVID-19 Pandemic with Patterns of Statewide Cancer Services New cancer cases at the time of SARS-Cov2 pandemic and related public health policies: A persistent and concerning decrease long after the end of the national lockdown COVID-19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population-and Registry-Based Study Changes in Newly Identified Cancer Among US Patients From Before COVID-19 Through the First Full Year of the Pandemic COVID-19 and the Financial Health of US Hospitals The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The authors declare no conflict of interest regarding this subject.